HK1167317A1 - 改進的 -腺苷甲硫氨酸製劑的藥代動力學 - Google Patents

改進的 -腺苷甲硫氨酸製劑的藥代動力學

Info

Publication number
HK1167317A1
HK1167317A1 HK12107972.3A HK12107972A HK1167317A1 HK 1167317 A1 HK1167317 A1 HK 1167317A1 HK 12107972 A HK12107972 A HK 12107972A HK 1167317 A1 HK1167317 A1 HK 1167317A1
Authority
HK
Hong Kong
Prior art keywords
improved pharmacokinetics
adenosylmethionine
formulations
adenosylmethionine formulations
pharmacokinetics
Prior art date
Application number
HK12107972.3A
Other languages
English (en)
Inventor
I David Macdonald
Nancy Harrison
Aniko Takacs-Cox
Robert Miller
Original Assignee
Methylation Sciences Internat Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2010/001879 external-priority patent/WO2011012990A2/en
Application filed by Methylation Sciences Internat Srl filed Critical Methylation Sciences Internat Srl
Publication of HK1167317A1 publication Critical patent/HK1167317A1/zh

Links

HK12107972.3A 2009-07-28 2012-08-14 改進的 -腺苷甲硫氨酸製劑的藥代動力學 HK1167317A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US200902291860A 2009-07-28 2009-07-28
PCT/IB2010/001879 WO2011012990A2 (en) 2009-07-28 2010-07-29 Improved pharmacokinetics of s-adenosylmethionine formulations

Publications (1)

Publication Number Publication Date
HK1167317A1 true HK1167317A1 (zh) 2012-11-30

Family

ID=54595551

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12107972.3A HK1167317A1 (zh) 2009-07-28 2012-08-14 改進的 -腺苷甲硫氨酸製劑的藥代動力學

Country Status (1)

Country Link
HK (1) HK1167317A1 (zh)

Similar Documents

Publication Publication Date Title
IL219961A0 (en) Abuse-resistant formulations
ZA201106050B (en) Dye-polymers formulations
IL269369A (en) The vehicles are improved
HK1170155A1 (zh) 具有增強的生物利用度的 -腺苷甲硫氨酸配製物
PL2442648T3 (pl) Preparaty neonikotynoidów niezawierające nmp
GB0919210D0 (en) Formulations
IL248077A0 (en) Formulations, salts and polymers of transnorsertraline and their uses
EP2593087A4 (en) PARENTERAL FORMULATIONS OF ELACYTARABINE DERIVATIVES
HK1161125A1 (zh) 含有阿利吉侖的蓋倫製劑
EP2506711A4 (en) HYPERSULATED DISACCHARIDE FORMULATIONS
SI2407155T1 (sl) Preparati na osnovi inekalcitola
AP2013006687A0 (en) Formulations
EP2512489A4 (en) METHOD OF PREPARING ACADESINE
GB201013513D0 (en) Formulations
GB201010667D0 (en) Formulations
HK1167317A1 (zh) 改進的 -腺苷甲硫氨酸製劑的藥代動力學
IL217390A0 (en) Formulations
AP2013006689A0 (en) Formulations
GB0914489D0 (en) Improved formulations
GB0917744D0 (en) Formulations
GB201018645D0 (en) Formulations
GB201018647D0 (en) Formulations
GB201012589D0 (en) Formulations
GB201010494D0 (en) Formulations
GB201008470D0 (en) Formulations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200803